Arnoud van 't Hof

Professor

Prof. Arnoud van ‘t Hof is Interventional Cardiologist and head of the department of Interventional Cardiology in Maastricht University Medical Center and Zuyderland Medical Center in Heerlen, the Netherlands. He has a long-standing research history in cardiovascular medicine, particularly in the field of primary angioplasty and acute coronary syndromes, with special interest in pre-hospital diagnosis and triage in the ambulance. He has been (co-) chairing international multi-center clinical trials in this field. He is a board member of the Acute Cardiac Care Association (ACCA) and editorial board member of the European Heart Journal Acute Cardiovascular Care and the Netherlands Heart Journal. He chaired the board of directors of the National Cardiovascular Data Registry (NCDR, now Nederlandse Hart Registratie (NHR) with specific interest for value based healthcare (VBHC) and data science. He recently joined the European Association of Preventive Cardiology (EAPC) with research on Cardiac Rehabilitation, Cardiovascular Prevention and Sports Medicine.

Prof. Arnoud van ‘t Hof has authored over 350 publications in peer-reviewed cardiovascular journals. He is an elected fellow of the ESC.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht

  • 2022
    • Donders, H. C. M., Veth, E. O., Edens, M. A., van 't Hof, A. W. J., de Lange, J., & Loos, B. G. (2022). The Effect of Periodontal Treatment on the Reactive Hyperemia Index. A 1-Year Follow-Up Pilot Study. Frontiers in Cardiovascular Medicine, 9, Article 851397. https://doi.org/10.3389/fcvm.2022.851397
    • Pustjens, T. F. S., Vranken, N. P. A., Hermanides, R. S., Rasoul, S., Ottervanger, J. P., & Van't Hof, A. W. J. (2022). Unraveling the Multitude of Etiologies in Myocardial Infarction With Nonobstructive Coronary Arteries. American Journal of Cardiology, 168, 17-21. https://doi.org/10.1016/j.amjcard.2021.12.015
    • Fabris, E., Menzio, S., Gregorio, C., Pezzato, A., Stolfo, D., Aleksova, A., Vitrella, G., Rakar, S., Perkan, A., Van't Hof, A. W. J., & Sinagra, G. (2022). Effect of prehospital treatment in STEMI patients undergoing primary PCI. Catheterization and Cardiovascular interventions, 99(5), 1500-1508. https://doi.org/10.1002/ccd.30153
    • Claassens, D. M. F., van Dorst, P. W. M., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., Hof, A. W. J. V., van der Harst, P., Barbato, E., Morisco, C., Gin, R. M. T. J., Asselbergs, F. W., Mosterd, A., Herrman, J. P. R., Dewilde, W. J. M., Postma, M. J., Deneer, V. H. M., ten Berg, J. M., & Boersma, C. (2022). Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial. American Journal of Cardiovascular Drugs, 22(2), 195-206. https://doi.org/10.1007/s40256-021-00496-4
    • Tolsma, R. T., Fokkert, M. J., van Dongen, D. N., Badings, E. A., van der Sluis, A., Slingerland, R. J., Riet, E. V., Ottervanger, J. P., & Hof, A. W. J. V. (2022). Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study. European Heart Journal: Acute Cardiovascular Care, 11(2), 160-169. https://doi.org/10.1093/ehjacc/zuab109
    • Ravaux, J. M., Van Kuijk, S. M. J., Di Mauro, M., Vernooy, K., Bidar, E., Van't Hof, A. W., Veenstra, L., Kats, S., Houterman, S., Maessen, J. G., Lorusso, R., & THI Registration Committee of The Netherlands Heart Registration (2022). Incidence and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Procedures: Data of The Netherlands Heart Registration (NHR). Journal of Clinical Medicine, 11(3), Article 560. https://doi.org/10.3390/jcm11030560
    • Bruninx, A., Scheenstra, B., Dekker, A., Maessen, J., Hof, A. V., Kietselaer, B., & Bermejo, I. (2022). Using clinical prediction models to personalise lifestyle interventions for cardiovascular disease prevention: A systematic literature review. Preventive Medicine Reports, 25, Article 101672. https://doi.org/10.1016/j.pmedr.2021.101672
    • Tavenier, A. H., Claassens, D. M. F., Hermanides, R. S., Vos, G. J. A., Bergmeijer, T. O., Kelder, J. C., Deneer, V. H. M., Hof, A. W. J. V. ., & Ten Berg, J. M. (2022). Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y(12) inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial. Catheterization and Cardiovascular interventions, 99(3), 676-685. https://doi.org/10.1002/ccd.29861
    • Heuts, S., Denessen, E. J. S., Daemen, J. H. T., Vroemen, W. H. M., Sels, J. W., Segers, P., Bekers, O., Hof, A. W. J. V., Maessen, J. G., van der Horst, I. C. C., & Mingels, A. M. A. (2022). Meta-Analysis Evaluating High-Sensitivity Cardiac Troponin T Kinetics after Coronary Artery Bypass Grafting in Relation to the Current Definitions of Myocardial Infarction. American Journal of Cardiology, 163, 25-31. https://doi.org/10.1016/j.amjcard.2021.09.049
    • Tavenier, A. H., Hermanides, R. S., Ottervanger, J. P., Tolsma, R., van Beurden, A., Slingerland, R. J., Ter Horst, P. G. J., Gosselink, A. T. M., Dambrink, J. H. E., van Leeuwen, M. A. H., Roolvink, V., Kedhi, E., Klungel, O. H., Belitser, S. V., Angiolillo, D. J., Pustjens, T., Rasoul, S., Gho, B., Stein, M., ... Hof, A. W. J. V. (2022). Impact of opioids on P2Y(12) receptor inhibition in patients with ST-elevationmyocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. European Heart Journal-Cardiovascular Pharmacotherapy, 8(1), 4-12. https://doi.org/10.1093/ehjcvp/pvaa095
    • Tavenier, A. H., Hermanides, R. S., Ottervanger, J. P., Belitser, S. V., Klungel, O. H., van't Hof, A. W. J., & ON-TIME 3 Investigators (2022). Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial. American Heart Journal, 243, 39-42. https://doi.org/10.1016/j.ahj.2021.08.011
    • Scheenstra, B., Princée, A. M. A., Imkamp, M. S. V., Kietselaer, B., Ganushchak, Y. M., Van't Hof, A. W. J., & Maessen, J. G. (2022). Last-minute cancellation of adult patients scheduled for cardiothoracic surgery in a large Dutch tertiary care centre. European Journal of Cardio-Thoracic Surgery, 61(1), 225-232. https://doi.org/10.1093/ejcts/ezab246
  • 2021
    • Ravaux, J. M., Di Mauro, M., Vernooy, K., Kats, S., Mariani, S., Ronco, D., Dato, G. A., Simons, J., Van't Hof, A. W., Maessen, J. G., & Lorusso, R. (2021). Permanent pacemaker implantation following transcatheter aortic valve implantation using self-expandable, balloon-expandable, or mechanically expandable devices: a network meta-analysis. EP Europace, 23(12), 1998-2009. https://doi.org/10.1093/europace/euab209
    • Fabris, E., Korjian, S., Coller, B. S., Ten Berg, J. M., Granger, C. B., Gibson, C. M., & van 't Hof, A. W. J. (2021). Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead. Thrombosis and Haemostasis, 121(12), 1562-1573. https://doi.org/10.1055/a-1414-5009
    • Donders, H. C. M., Veth, E. O., van 't Hof, A. W. J., de Lange, J., & Loos, B. G. (2021). The association between periodontitis and cardiovascular risks in asymptomatic healthy patients. International journal of cardiology. Cardiovascular risk and prevention, 11, Article 200110. https://doi.org/10.1016/j.ijcrp.2021.200110
    • Lux, A., Veenstra, L. F., Kats, S., Dohmen, W., Maessen, J. G., Hof, A. W. J. V., & Maesen, B. (2021). Urgent transcatheter aortic valve implantation in an all-comer population: a single-centre experience. BMC Cardiovascular disorders, 21(1), Article 550. https://doi.org/10.1186/s12872-021-02347-1
    • Buttgereit, T., Palmowski, A., Forsat, N., Boers, M., Witham, M. D., Rodondi, N., Moutzouri, E., Navidad, A. J. Q., van't Hof, A. W. J., van der Worp, B., Coll-Planas, L., Voshaar, M., de Wit, M., da Silva, J., Stegemann, S., Bijlsma, J. W., Koeller, M., Mooijaart, S., Kearney, P. M., & Buttgereit, F. (2021). Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials. Age and Ageing, 50(6), 1988-1996. https://doi.org/10.1093/ageing/afab147
    • Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, V., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., ten Berg, J. M., van ‘t Hof, A. W. J., & Hermanides, R. S. (2021). Feasibility and safety of cangrelor in patients with suboptimal P2Y<inf>12</inf> inhibition undergoing percutaneous coronary intervention: The Dutch Cangrelor registry. European heart journal open, 1(3), Article 1–3. https://doi.org/10.1093/ehjopen/oeab028
    • Arslan, F., Damman, P., Zwart, B., Appelman, Y., Voskuil, M., de Vos, A., van Royen, N., Jukema, J. W., Waalewijn, R., Hermanides, R. S., Woudstra, P., ten Cate, T., Lemkes, J. S., Vink, M. A., Balder, W., van der Wielen, M. L. J., Vlaar, P. J., van der Heijden, D. J., Assa, S., ... ten Berg, J. M. (2021). 2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation: Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups. Netherlands Heart Journal, 29(11), 557-565. https://doi.org/10.1007/s12471-021-01593-4
    • Luijkx, J., Winkler, P., & van 't Hof, A. (2021). Clopidogrel or ticagrelor alongside dabigatran in acute coronary syndrome and indication for NOAC: a study rationale. Future Cardiology, 18(4), 265-274. https://doi.org/10.2217/fca-2021-0085
    • Piccolo, R., Bonaa, K. H., Efthimiou, O., Varenne, O., Urban, P., Kaiser, C., Raber, L., de Belder, A., Remkes, W., van't Hof, A. W. J., Stankovic, G., Lemos, P. A., Wilsgaard, T., Reifart, J., Rodriguez, A. E., Ribeiro, E. E., Serruys, P. W. J. C., Abizaid, A., Sabate, M., ... Valgimigli, M. (2021). Drug-Eluting or Bare-Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization. Journal of the American Heart Association, 10(20), Article e018828. https://doi.org/10.1161/JAHA.120.018828
    • Tavenier, A. H., Hermanides, R. S., Ottervanger, J. P., Belitser, S. V., Klungel, O. H., Appelman, Y., van Leeuwen, M. A. H., & van 't Hof, A. W. J. (2021). Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial. Frontiers in Cardiovascular Medicine, 8, Article 707814. https://doi.org/10.3389/fcvm.2021.707814
    • Scherrenberg, M., Zeymer, U., Schneider, S., Velde, A. E. V., Wilhelm, M., Hof, A. W. J. V., Kolkman, E., Prins, L. F., Prescott, E., Iliou, M. C., Pena-Gill, C., Ardissino, D., De Kluiver, E. P., & Dendale, P. (2021). EU-CaRE study: Could exercise-based cardiac telerehabilitation also be cost-effective in elderly?International Journal of Cardiology, 340, 1-6. https://doi.org/10.1016/j.ijcard.2021.08.024
    • Olie, R. H., van der Meijden, P. E. J., Vries, M. J. A., Veenstra, L., van't Hof, A. W. J., ten Berg, J. M., Henskens, Y. M. C., & ten Cate, H. (2021). Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events. Netherlands Heart Journal, 29(10), 525-535. https://doi.org/10.1007/s12471-021-01606-2
    • Ravaux, J. M., Van Kuijk, S. M. J., Di Mauro, M., Vernooy, K., Bidar, E., Mariani, S., Dato, G. A., Van't Hof, A. W., Veenstra, L., Kats, S., Houterman, S., Maessen, J. G., Lorusso, R., & Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration (2021). Incidence and predictors of permanent pacemaker implantation after surgical aortic v alve replacement: Data of the Netherlands Heart Registration (NHR). Journal of Cardiac Surgery, 36(10), 3519-3527. https://doi.org/10.1111/jocs.15803
    • De Luca, G., Debel, N., Cercek, M., Jensen, L. O., Vavlukis, M., Calmac, L., Johnson, T., Rourai Ferrer, G., Ganyukov, V., Wojakowski, W., Kinnaird, T., von Birgelen, C., Cottin, Y., IJsselmuiden, A., Tuccillo, B., Versaci, F., Royaards, K.-J., ten Berg, J., Laine, M., ... Verdoia, M. (2021). Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry. Atherosclerosis, 332, 48-54. https://doi.org/10.1016/j.atherosclerosis.2021.06.926
    • Scheenstra, B., Mohansingh, C., Bongers, B., Dahmen, S., Wouters, Y., Lenssen, T., Geerlings, P., Knols, H., van Kuijk, S., Kimman, M., Nieman, M., Maessen, J., van 't Hof, A., & Sardari Nia, P. (2021). Personalized teleprehabilitation in elective cardiac surgery: Personalized teleprehabilitation in elective cardiac surgery. European Heart Journal - Digital Health, 2(3), 477-486. https://doi.org/10.1093/ehjdh/ztab041
    • Snoek, J. A., Meindersma, E. P., Prins, L. F., van't hof, A. W. J., de Boer, M.-J., Hopman, M. T., Eijsvogels, T. M. H., & de Kluiver, E. P. (2021). The sustained effects of extending cardiac rehabilitation with a six-month telemonitoring and telecoaching programme on fitness, quality of life, cardiovascular risk factors and care utilisation in CAD patients: The TeleCaRe study. Journal of Telemedicine and Telecare, 27(8), 473-483. https://doi.org/10.1177/1357633X19885793
    • Eser, P., Marcin, T., Prescott, E., Prins, L. F., Kolkman, E., Bruins, W., van der Velde, A. E., Gil, C. P., Iliou, M. C., Ardissino, D., Zeymer, U., Meindersma, E. P., Van'tHof, A. W. J., de Kluiver, E. P., & Wilhelm, M. (2021). Predictors for one-year outcomes of cardiorespiratory fitness and cardiovascular risk factor control after cardiac rehabilitation in elderly patients: The EU-CaRE study. PLOS ONE, 16(8), Article e0255472. https://doi.org/10.1371/journal.pone.0255472
    • Marcin, T., Eser, P., Prescott, E., Prins, L. F., Kolkman, E., Bruins, W., van der Velde, A. E., Pena Gil, C., Iliou, M.-C., Ardissino, D., Zeymer, U., Meindersma, E. P., Van't Hof, A. W. J., de Kluiver, E. P., & Wilhelm, M. (2021). Changes and prognostic value of cardiopulmonary exercise testing parameters in elderly patients undergoing cardiac rehabilitation: The EU-CaRE observational study. PLOS ONE, 16(8), Article e0255477. https://doi.org/10.1371/journal.pone.0255477
    • Bor, W. L., Zheng, K. L., Tavenier, A. H., Gibson, C. M., Granger, C. B., Bentur, O., Lobatto, R., Postma, S., Coller, B. S., van 't Hof, A. W. J., & Ten Berg, J. M. (2021). Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction. Eurointervention, 17(5), 401-410. https://doi.org/10.4244/EIJ-D-21-00287
    • Pustjens, T. F. S., Meerman, A., Vranken, N. P. A., Ruiters, A. W., Gho, B., Stein, M., Ilhan, M., Veenstra, L., Winkler, P., Lux, A., Rasoul, S., & van't Hof, A. W. J. (2021). Importance of confirming the underlying diagnosis in patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): a single-centre retrospective cohort study. BMC Cardiovascular disorders, 21(1), Article 357. https://doi.org/10.1186/s12872-021-02176-2
    • Claassens, D. M. F., Gimbel, M. E., Bergmeijer, T. O., Vos, G. J. A., Hermanides, R. S., van der Harst, P., Barbato, E., Morisco, C., Gin, R. M. T. J., de Vrey, E. A., Heestermans, T. A. C. M., Jukema, J. W., von Birgelen, C., Waalewijn, R. A., Hofma, S. H., den Hartog, F. R., Voskuil, M., Van't Hof, A. W. J., Asselbergs, F. W., ... ten Berg, J. M. (2021). Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients. International Journal of Cardiology, 334, 10-17. https://doi.org/10.1016/j.ijcard.2021.04.029
    • Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, A. J. H. M., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., ten Berg, J. M., van 't Hof, A. W. J., & Hermanides, R. S. (2021). Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry. BMC Cardiovascular disorders, 21(1), Article 292. https://doi.org/10.1186/s12872-021-02093-4
    • de Breet, C. P. D. M., Zwaveling, S., Vries, M. J. A., van Oerle, R. G., Henskens, Y. M. C., Van't Hof, A. W. J., van der Meijden, P. E. J., Veenstra, L., ten Cate, H., & Olie, R. H. (2021). Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy. Frontiers in Cardiovascular Medicine, 8, Article 679934. https://doi.org/10.3389/fcvm.2021.679934
    • Willemsen, R. T. A., & van 't Hof, A. W. J. (2021). Chest pain triage: gut feeling or protocol-based care?Netherlands Heart Journal, 29(6), 309-310. https://doi.org/10.1007/s12471-021-01589-0
    • Ravaux, J. M., Di Mauro, M., Vernooy, K., Mariani, S., Ronco, D., Simons, J., Van't Hof, A. W., Veenstra, L., Kats, S., Maessen, J. G., & Lorusso, R. (2021). Impact of Bundle Branch Block on Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation: A Meta-Analysis. Journal of Clinical Medicine, 10(12), Article 2719. https://doi.org/10.3390/jcm10122719
    • Ravaux, J., Di Mauro, M., Vernooy, K., van 't Hof, A., Veenstra, L., Kats, S., Maessen, J., & Lorusso, R. (2021). One-year pacing dependency after pacemaker implantation in patients undergoing transcatheter aortic valve implantation: Systematic review and meta-analysis. Journal of Thoracic and Cardiovascular Surgery, 6, 41-55.e15. https://doi.org/10.1016/j.xjon.2021.02.002
    • Lux, A., Vainer, J., Theunissen, R. A. L. J., Veenstra, L. F., Kasperski, I., Gho, B. C. G., Stein, M., Ilhan, M., Ruiters, A. W., Winkler, P. J. C., van Beurden, A., Dohmen, W., Rasoul, S., van 't Hof, A. W. J., & South Limburg Interventional Cardiology Group, the Netherlands (2021). Sharing primary percutaneous coronary intervention care: first experiences with South Limburg ST-elevation myocardial infarction network. Netherlands Heart Journal, 29(6), 348-353. https://doi.org/10.1007/s12471-021-01541-2
    • Kjesbu, I. E., Mikkelsen, N., Sibilitz, K. L., Wilhelm, M., Pena-Gil, C., Gonzalez-Salvado, V., Iliou, M. C., Zeymer, U., Meindersma, E. P., Ardissino, D., van der Velde, A. E., Van't Hof, A. W. J., de Kluiver, E. P., & Prescott, E. (2021). Greater burden of risk factors and less effect of cardiac rehabilitation in elderly with low educational attainment: The Eu-CaRE study. European Journal of Preventive Cardiology, 28(5), 513-519. Article 2047487320921485. https://doi.org/10.1177/2047487320921485
    • Gonzalez-Salvado, V., Pena-Gil, C., Lado-Baleato, O., Cadarso-Suarez, C., Prada-Ramallal, G., Prescott, E., Wilhelm, M., Eser, P., Iliou, M.-C., Zeymer, U., Ardissino, D., Bruins, W., van der Velde, A. E., Van't Hof, A. W. J., de Kluiver, E. P., Kolkman, E. K., Prins, L., & Gonzalez Juanatey, J. R. (2021). Offering, participation and adherence to cardiac rehabilitation programmes in the elderly: a European comparison based on the EU-CaRE multicentre observational study. European Journal of Preventive Cardiology, 28(5), 558-568. https://doi.org/10.1093/eurjpc/zwaa104
    • Ravaux, J. M., Di Mauro, M., Vernooy, K., Van't Hof, A. W., Veenstra, L., Kats, S., Maessen, J. G., & Lorusso, R. (2021). Do Women Require Less Permanent Pacemaker After Transcatheter Aortic Valve Implantation? A Meta-Analysis and Meta-Regression. Journal of the American Heart Association, 10(7), Article e019429. https://doi.org/10.1161/JAHA.120.019429
    • Tavenier, A. H., Hermanides, R. S., Fabris, E., Angiolillo, D. J., & van't Hof, A. W. J. (2021). Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI. International Journal of Cardiology, 328, 40-45. https://doi.org/10.1016/j.ijcard.2020.11.042
    • Claassens, D. M. F., Bergmeijer, T. O., Vos, G. J. A., Hermanides, R. S., 't Hof, A. W. J. V., van der Harst, P., Barbato, E., Morisco, C., Gin, R. M. T. J., Asselbergs, F. W., Mosterd, A., Herrman, J.-P. R., Dewilde, W. J. M., Janssen, P. W. A., Kelder, J. C., Mahmoodi, B. K., Deneer, V. H. M., & ten Berg, J. M. (2021). Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis. Circulation-Cardiovascular Interventions, 14(4), 402-411. Article 009434. https://doi.org/10.1161/circinterventions.120.009434
    • Snoek, J. A., Prescott, E. I., van der Velde, A. E., Eijsvogels, T. M. H., Mikkelsen, N., Prins, L. F., Bruins, W., Meindersma, E., Gonzalez-Juanatey, J. R., Pena-Gil, C., Gonzalez-Salvado, V., Moatemri, F., Iliou, M. C., Marcin, T., Eser, P., Wilhelm, M., Van't Hof, A. W. J., & de Kluiver, E. P. (2021). Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe: A Randomized Clinical Trial. JAMA Cardiology, 6(4), 463-468. https://doi.org/10.1001/jamacardio.2020.5218
    • Marchal, S., van 't Hof, A. W., Bilo, H. J., Deijns, S. J., Heeg, J. E., Schoenmakers, M., Schouwink, M., Schwantje, O., Bots, M. L., Hoes, A. W., & Hollander, M. (2021). Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an observational study in general practice. BJGP Open, 5(2), Article 0099. https://doi.org/10.3399/BJGPO.2020.0099
    • Fabris, E., ten Berg, J. M., Hermanides, R. S., Ottervanger, J. P., Dambrink, J. H. E., Gosselink, A. T. M., Sinagra, G., Koopmans, P. C., Giannitsis, E., Hamm, C., & Hof, A. W. J. V. (2021). NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial. American Heart Journal, 233, 78-85. https://doi.org/10.1016/j.ahj.2020.12.017
    • Hoedemaker, N. P. G., de Winter, R. J., Hof, A. V., Kolkman, E., & Damman, P. (2021). Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry. American Journal of Cardiovascular Drugs, 21(2), 219-229. https://doi.org/10.1007/s40256-020-00427-9
    • Weerts, J., Pustjens, T., Amin, E., Ilhan, M., Veenstra, L. F., Theunissen, R. A. L. J., Vainer, J., Stein, M., Ruiters, L. A. W., Gho, B. C. G., Van't Hof, A. W. J., & Rasoul, S. (2021). Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions. Catheterization and Cardiovascular interventions, 97(2), 247-256. https://doi.org/10.1002/ccd.28753
    • van Dongen, D. N., Badings, E. A., Fokkert, M. J., Tolsma, R. T., van der Sluis, A., Slingerland, R. J., Hof, A. W. J. V., & Ottervanger, J. P. (2021). Pre-hospital versus hospital acquired HEART score for risk classification of suspected non ST-elevation acute coronary syndrome. European Journal of Cardiovascular Nursing, 20(1), 40-47. Article 1474515120927867. https://doi.org/10.1177/1474515120927867